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Key points
 Alpha-melanocyte stimulating hormone (α-MSH) is an anorexigenic peptide. Injection of the
α-MSH analog MTII into the ventral tegmental area (VTA) decreases food and sucrose intake
and food reward.
 Melanocortin-3 receptors (MC3R) are highly expressed in the VTA, suggesting that the effects
of intra-VTA α-MSH may be mediated by α-MSH changing the activity of MC3R-expressing
VTA neurons.
 α-MSH increased the firing rate of MC3R VTA neurons in acute brain slices from mice,
although it did not affect the firing rate of non-MC3R VTA neurons.
 The α-MSH induced increase in MC3R neuron firing rate is probably activity-dependent, and
was independent of fast synaptic transmission and intracellular Ca2+ levels.
 These results help us to better understand how α-MSH acts in the VTA to affect feeding and
other dopamine-dependent behaviours.
Abstract Themesocorticolimbic dopamine system, the brain’s reward system, regulatesmultiple
behaviours, including food intake and food reward. There is substantial evidence that the
melanocortin system of the hypothalamus, an important neural circuit controlling feeding and
body weight, interacts with the mesocorticolimbic dopamine system to affect feeding, food
reward and body weight. For example, melanocortin-3 receptors (MC3Rs) are expressed in the
ventral tegmental area (VTA) and our laboratory previously showed that intra-VTA injection of
the MC3R agonist, MTII, decreases home-cage food intake and operant responding for sucrose
pellets. However, the cellular mechanisms underlying the effects of intra-VTA alpha-melanocyte
stimulating hormone (α-MSH) on feeding and food reward are unknown. To determine how
α-MSH acts in the VTA to affect feeding, we performed electrophysiological recordings in acute
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brain slices from mice expressing enhanced yellow fluorescent protein in MC3R neurons to test
how α-MSH affects the activity of VTAMC3R neurons. α-MSH significantly increased the firing
rate of VTAMC3R neurons without altering the activity of non-MC3R expressing VTA neurons.
In addition, the α-MSH-induced increase in MC3R neuron activity was independent of fast
synaptic transmission and intracellular Ca2+ levels. Finally, we show that the effect of α-MSH
on MC3R neuron firing rate is probably activity-dependent. Overall, these studies provide an
important advancement in the understanding of how α-MSH acts in the VTA to affect feeding
and food reward.
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Introduction
The World Health Organization estimates that obesity
rates have almost tripled worldwide from 1975 onward
(World Health Organization, 2018). The rapid rise in
obesity is amajor health concern because obesity increases
the risk for many diseases, such as heart disease, diabetes,
cancer and stroke (Afshin et al. 2017). The increased pre-
valence of obesity is largely attributed to an increase in
food consumption (Finkelstein et al. 2005; Hall et al.
2009; Swinburn et al. 2009; Swinburn et al. 2011). Thus,
an understanding of the mechanisms of food intake
and weight gain is important for the development of
new effective treatments that aim to prevent and reverse
obesity.
The melanocortin system has been widely shown to
play an important role in the control of feeding and
body weight. This system encompasses two neuronal
populations in the arcuate nucleus of the hypothalamus:
pro-opiomelanocortin (POMC) expressing neurons
and agouti-related protein/neuropeptide-Y (AgRP/NPY)
expressing neurons, as well as the peptides released by
these neurons and the downstream receptors of these
peptides (Roseberry et al. 2015). POMC is a propeptide
that is post-translationally processed to produce the
melanocyte-stimulating hormones (α-, β-, and γ-MSH).
α-, β-, and γ-MSH are agonists to the centrally
expressed melanocortin receptors, melanocortin-3 and
melanocortin-4 receptors (MC3/4Rs), whereas AgRP is
an inverse-agonist to the MC3/4Rs (Roseberry et al.
2015). AgRP/NPY and POMC neurons respond to the
energy state of an animal and function in an opposing
manner. For example, an energy deficit or hunger state
activates AgRP/NPY neurons (Hahn et al. 1998; Takahashi
& Cone, 2005), whereas an energy surplus or satiated
state activates POMC neurons (Singru et al. 2007; Wu
et al. 2014). In addition, activation of AgRP/NPY neurons
or injection of MC3/4R antagonists increases feeding
(Fan et al. 1997; Ollmann et al. 1997; Aponte et al.
2011; Krashes et al. 2011), whereas activation of POMC
neurons or injection of MC3/4R agonists decrease feeding
(Fan et al. 1997; Pierroz et al. 2002; Aponte et al.
2011; Zhan et al. 2013). The melanocortin system is
clearly an important regulator of food intake and sub-
stantial evidence indicates that this system interacts with
other brain nuclei and neural systems, including the
mesocorticolimbic dopamine system, to regulate food
intake and body weight.
Themesocorticolimbic dopamine system is the primary
neural circuit for reward and motivated behaviour and
also regulates food reward, feeding and body weight
(Wise, 2004; Lutter & Nestler, 2009; Kenny, 2011; Volkow
et al. 2011; Roseberry et al. 2015). The mesocorticolimbic
dopamine system comprises dopamine neurons in the
ventral tegmental area (VTA) and the downstream targets
of dopamine neurons such as the nucleus accumbens
(NAc), prefrontal cortex (PFC), olfactory tubercle and
hippocampus. Numerous studies show the importance of
dopamine for food intake and food reward. For example,
dopamine-deficient mice are aphagic (Zhou & Palmiter,
1995) and blocking dopamine receptors systemically or
in the NAc decreases operant responding for food in rats
(Beninger et al. 1987; Cousins et al. 1994; Koch et al.
2000). There is also substantial evidence that intra-VTA
injection of a number of feeding-related peptides alters
food intake and food reward (Liu & Borgland, 2015). This
includes the injection of analogues of α-MSH and AgRP
into the VTA. For example, our laborarory has shown
that injection of the MC3/4R agonist, MTII, directly into
the VTA decreases home-cage food intake, the intake of
sucrose and saccharin intake in two-bottle choice tests,
as well as operant responding for sucrose pellets, whereas
injection of the MC3/4R antagonist, SHU9119, into
the VTA increases home-cage food intake and operant
responding for sucrose pellets (Roseberry, 2013; Yen &
Roseberry, 2015; Shanmugarajah et al. 2017). Neverthe-
less, how α-MSH acts in the VTA at the cellular level to
regulate feeding and other reward related behaviours is
unknown.
Intra-VTA α-MSH may affect food intake and food
reward by regulating VTA dopamine neuron activity.
This is supported by studies first conducted in the 1980s
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showing that intra-VTA injection of α-MSH increases
dopamine turnover in the NAc (Torre & Celis, 1986,
1988). Furthermore, intra-VTA α-MSH and MC3/4R
agonists increase dopamine-dependent behaviours, such
as rearing, grooming and locomotor activity (Torre &
Celis, 1986, 1988; Klusa et al. 1999; Sanchez et al. 2001).
Additional evidence indicates that the melanocortin and
mesocorticolimbic dopamine systems interact. POMC
and AgRP neurons project to the VTA (King & Hentges,
2011;Dietrich et al.2012) andbothMC3RsandMC4Rsare
expressed in dopamine and non-dopamine VTA neurons
(Roselli-Rehfuss et al. 1993; Liu et al. 2003; Lippert et al.
2014). However, the MC3R is expressed at much higher
levels in the VTA than the MC4R (Roselli-Rehfuss et al.
1993; Liu et al. 2003; Lippert et al. 2014), suggesting that
the effects of α-MSH and AgRP in the VTA are probably a
result of the actions on MC3Rs. Thus, α-MSH can clearly
act in the VTA to affect food intake, food reward and other
reward behaviours, probably via activation of dopamine
neurons expressing theMC3R.However, how α-MSH acts
on MC3R-expressing VTA dopamine neurons to regulate
food intake and reward behaviour and also to increase
dopamine turnover in the NAc remains unknown. Thus,
in the present study, we investigated whether α-MSH
alters the activity of VTAMC3R expressing neurons using
electrophysiology in brain slices from transgenic mice
expressing enhanced yellow fluorescent protein (EYFP)
in their MC3R neurons.
Methods
Ethical approval
All of the protocols and procedures were approved by
the Institutional Animal Care and Use Committee at
Georgia State University (approval reference no. A17016)
and conformed to the NIH Guide for the Care and Use
of Laboratory Animals. The investigators understand and
complied with the ethical standards of the Journal of
Physiology outlined in Grundy 2015 for all experiments
(Grundy, 2015).
Animals
Male and female transgenic mice expressing EYFP in
MC3R neurons (5–14 weeks old, 20–25 g, fed ad libitum)
on a mixed C57/129 background were used in all
experiments. Mice were generated by crossing transgenic
mice expressing Cre recombinase tethered to the MC3R
gene product by a 2A-self-cleaving peptide (Pei et al. 2018)
(generously provided by Dr David P. Olson, University of
Michigan,AnnArbor,MI,USA)withaCre inducibleEYFP
Ai3 transgenic mouse line from The Jackson Laboratory
(Bar Harbor, ME, USA) (Stock # 007903). The specificity
of Cre expression in MC3R neurons was confirmed pre-
viously in a separate study describing the creation and
validation of this mouse (Pei et al. 2018). In total, 84
neurons from 60 mice were used in the experiments
described in the present study. Five neurons from four
mice were excluded from the study because the identity of
the neuron was unconfirmed or the neuron died during
the experiment.
RNAscope in situ hybridization (ISH) assay
RNAscope ISHwasperformedas describedpreviously (Pei
et al. 2018). Briefly, adult mice were quickly decapitated
under anaesthesia. The brains were then removed, flash
frozenwith 2-methylbutane at –20°C and stored at –80°C.
Coronal brain sections (16 μm) were cut with a cryostat
and thaw mounted onto SuperFrost Plus Slides (Thermo
Fisher Scientific,Waltham,MA,USA). ISHwas performed
according to the RNAscope R© 2.5 HD Duplex Detection
Kit User Manual for Fresh Frozen Tissue (Advanced Cell
Diagnostics, Inc., Newark, CA, USA). The probes used
were: RNAscope R© Probe-Mm-Mc3r-C1, Cat No. 412541;
RNAscope R© Probe-Cre-C2, Cat No. 312281-C2.
Slice preparation and electrophysiology
Acute brain slices were prepared in a manner similar
to that described previously (Roseberry et al. 2007;
Stuhrman & Roseberry, 2015; West & Roseberry, 2017).
Briefly, adult mice were anaesthetized with isofluorane
and decapitated. The brain was then removed and placed
in carbogen (95% O2 and 5% CO2) saturated ice-cold
sucrose cutting solution containing (in mM): 205 sucrose,
2.5KCl, 0.5CaCl2, 1.25NaH2PO4, 7.5MgCl2, 11.1 glucose,
21.4 NaHCO3 and 0.6 kynurenic acid. A brain block
containing the VTA was made, and pseudo-horizontal
sections (220 μm) were cut with a vibrating blade micro-
tome. Slices were then incubated in artificial cerebral
spinal fluid (aCSF) containing (in mM): 126 NaCl, 2.5
KCl, 2.4 CaCl2, 1.2 NaH2PO4, 1.2 MgCl2, 11.1 glucose,
21.4 NaHCO3 and 1 kynurenic acid at 35°C for 30 min
and then transferred to aCSF lacking kynurenic acid
for storage before recording. Slices were placed in a
recording chamber and perfused with carbogen-saturated
aCSF at a flow rate of 1–2 ml min–1. Whole-cell and
loose cell-attached recordings were made using an Axon
multiclamp 700B microelectrode amplifier (Molecular
Devices, Sunnyvale, CA, USA) and AxoGraph software
(https://axograph.com). MC3R-expressing neurons were
identified by the presence of EYFP using a fluorescence
microscope and were patch clamped under gradient
contrast optics.
Cell firing was recorded in either the loose-cell
attached or whole-cell configuration. Loose cell-attached
C© 2019 The Authors. The Journal of Physiology C© 2019 The Physiological Society
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recordings were obtained with electrodes (7.0–10.0 M)
filled with a Na-Hepes based internal solution containing
(in mM): 135 Na-Hepes and 20 NaCl, adjusted to
290 mosmol with water. Whole-cell recordings were
obtained with electrodes (2.0–3.0 M) filled with a
potassiumgluconate (KGluconate) based internal solution
containing (in mM): 128 KGluconate, 10 NaCl, 1 MgCl2,
10 Hepes, 2 ATP, 0.3 GTP, 10 creatine phosphate,
10 BAPTA or 1 EGTA, and 0.1% biocytin. The inter-
nal solution contained EGTA for the experiments
examining the effect of α-MSH on MC3R neuron activity
under reduced calcium buffering conditions. The inter-
nal solution contained BAPTA for all other whole-cell
recordings. Corrections were not made for the liquid
junction potential, which was calculated for each inter-
nal solution used as: KGluconate 10 mM BAPTA, 13.9;
KGluconate 1 mM EGTA, 14.7. Series resistance values
were3–15M. If the series resistance increased bymore
than 20%, the experiment was terminated or excluded
from analysis. The basic action potential characteristics
of VTA MC3R and non-MC3R neurons were analysed
using the event detection protocol in AxoGraph. Briefly,
spontaneously firing action potentials (e.g. spontaneous
firing in the absence of current injection) were captured
using the event detection protocol, which aligns all action
potentials at threshold. The rise time (10–90%) and action
potential half-width (at 50% maximum amplitude) were
thenobtained from the values calculated byAxoGraph and
the average values were calculated for each individual cell.
To measure hyperpolarization-activated cation currents
(H-current), neurons were voltage clamped at –60 mV
and 2 s voltage steps were applied in increasing increments
of –10 mV from –50 to –100 mV with a 1 s inter-step
interval. Cell firing was recorded in voltage clamp mode
for loose-cell attached recordings and current clamp
mode for whole-cell recordings. Whole-cell recordings
were conducted in the presence of fast synaptic blockers
[10 μM 6,7-dinitroquinoxaline-2,3-dione (DNQX) and
100 μM picrotoxin] and, if the cell was not firing, positive
current was injected (5–55 pA). In addition, if the cell
stopped firing or did not fire for at least 1 min during
baseline recordings or during the first 2 min on adding
the α-MSH, the experiment was terminated or excluded
from the analysis. Membrane potential was recorded in
current clamp mode in the presence of tetrodotoxin
(1μM, TTX). For experiments testing the effect of α-MSH
on membrane current, neurons were voltage clamped
at –60 mV, and slow voltage ramps were applied from
–100 mV to 0 mV at 100 mV s−1 every 30 s in the pre-
sence of TTX. For experiments testing the effect ofα-MSH
on current-step evoked action potentials, the neurons
were held at –70 mV and 2 s current steps of 5 pA
were applied at increasing amplitudes (5–50 pA) with
a 1 s inter-step interval. The current-step protocol was
repeated every minute and, if the current steps failed to
evoke action potentials or if the number of evoked action
potentials decreased over time during baseline recording,
the experiment was terminated. The effects of α-MSH on
all parameters (change in firing rate, membrane potential,
current, or membrane resistance) were determined by
averaging the baseline value for the entire 5 min prior to
the addition of α-MSH, and comparing that to the average
value of the 4–6 min period after the addition of α-MSH.
These time points were analysed for all cells regardless of
any apparent differences in the timing of theα-MSH effect
between cells. For all experiments, cells were held for at
least 10minprior to drug application to allow for diffusion
of the internal solution into the cell and to ensure stability
of the recording prior to drug addition.
Immunohistochemistry
To identify VTA neurons used in electrophysiology
experiments as dopamine or non-dopamine neurons,
0.1% biocytin was included in the internal pipette
solution, and the slices were fixed and stained for TH
post hoc. After the recording was terminated, the pipette
was slowly removed from the neuron to allow the
membrane to reseal. The brain slices were transferred
to 4% paraformaldehyde and incubated at 4°C for 1–4
days, followed by washing and storage in PBS at 4°C until
processing. Brain slices were then incubated with blocking
buffer (5% normal goat serum, 0.2% Triton X-100, and
0.1% BSA in PBS) for 6 h at room temperature. The
brain slices were then washed with PBS and incubated
with a mouse monoclonal anti-TH antibody (dilution
1:1500; Millipore, Billerica, MA, USA; catalogue no.
MAB318, lot no. NG1752067; RRID:AB_2201528) in
antibody incubation buffer (0.2% Triton X-100 and
1% BSA in PBS) overnight at 4˚C. Brain slices were
washed with PBS the next day and incubated with
streptavidin Alexa Fluor 594 (dilution 1:1000; Invitrogen,
Carlsbad, CA, USA) and goat anti-mouse Alexa Fluor 647
(dilution 1:300, Jackson ImmunoResearch, West Grove,
PA, USA) in antibody incubation buffer for 4 h at
room temperature. The brain slices were then mounted
to slides with gelvatol mounting media containing 10%
1,4-diazabicyclo[2.2.2]octane and imaged at 20× with a
confocal microscope (LSM 700; Carl Zeiss, Oberkochen,
Germany). Recorded neurons were identified as either
TH-positive, TH-negative or unidentifiable. Recorded
neurons positive for biocytin (red fluorescence) and TH
(magenta fluorescence) were identified as TH-positive,
and neurons positive for biocytin but negative for TH
were identified as TH-negative. Recorded neurons were
labelled as unidentifiable if the brain slice containing the
recorded neuron was damaged during processing, if a
biocytin labelled neuron could not be located in the brain
slice, or if multiple neurons were labelled for biocytin
C© 2019 The Authors. The Journal of Physiology C© 2019 The Physiological Society
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(which precluded the identification of the exact cell used
in the experiment).
Drugs
α-MSH was purchased from Bachem (Torrance, CA,
USA). TTX was purchased from Tocris Biosciences
(Minneapolis, MN, USA). All other reagents were
obtained from common commercial sources.
Statistical analysis
Data are represented as the mean± SEM unless otherwise
noted. Data were stored and analysed using AxoGraph
X, version 1.3.5, LabChart, version 7.3.6 (ADInstruments,
Sydney, NSW, Australia) and Excel, version 14.0 (Micro-
soft Corp. Redmond,WA, USA). Statistics were calculated
using SigmaStat, version 11.0 (Systat Software, Inc.,
Chicago, IL, USA). To test the hypothesis that α-MSH
changes the activity of VTA MC3R and non-MC3R
neurons (firing rate, membrane potential, membrane
resistance, rheobase, etc.), data were initially tested
for normality using the Shapiro–Wilk test and were
then analysed with Student’s paired t tests, under the
assumption of normality, or with Wilcoxon signed-rank
tests as appropriate. To test the hypothesis that the
electrical properties and action potentials of MC3R and
non-MC3R VTA neurons are different, data were initially
tested for normality using the Shapiro–Wilk test and were
then analysed with Student’s t tests, under the assumption
of normality, or with the Mann–Whitney U test as
appropriate. To test the hypothesis that α-MSH increases
the number of current-step evoked action potentials, we
used a two-way repeated measures ANOVA with Tukey’s
post hoc tests, under the assumption of normality. P< 0.05
was considered statistically significant a priori. In general,
five to eight cells from five to seven mice were used in
experiments examining the effects of α-MSH on VTA
neuron activity.
Results
We identified MC3R-expressing VTA neurons (‘VTA
MC3R neurons’) for electrophysiological recordings by
visualizing EYFP in cells from transgenic mice that
specifically express EYFP in MC3R-expressing neurons.
Thesemicewere generatedby crossingmice expressingCre
recombinase inMC3Rneurons (MC3RCre) (Pei et al. 2018)
with a Cre inducible EYFP mouse line (Fig. 1A). MC3R
neurons were located in the medial VTA spanning the
entire anterior–posterior extent of the VTA (Fig. 1A and
B). The specificity of Cre expression in MC3R-expressing
neurons of MC3RCre mice was previously confirmed in
the arcuate nucleus, ventromedial nucleus and the lateral
hypothalamus (Pei et al. 2018). We extended this study
and also tested the specificity of Cre expression in the VTA
using RNAscope ISH in MC3RCre mice. MC3R and Cre
mRNAs were also colocalized in the VTA, demonstrating
that Cre is specifically expressed in MC3R-expressing
neurons within the VTA ofMC3RCre mice (Fig. 1C–E).
We first characterized the electrical properties of VTA
MC3R neurons because VTA MC3R neurons are a novel
population of VTA neurons that have not been des-
cribed previously. We measured capacitance, membrane
resistance and the presence of H-current in 59 MC3R
neurons and 12 neighbouring non-MC3R neurons. VTA
MC3R neurons had a significantly smaller capacitance
(MC3R neuron, 13.27 ± 0.50 pF; Non-MC3R neuron,
23.06 ± 1.32 pF; mean difference = 9.79; P < 0.001;
Mann–Whitney U test) (Fig. 2A) and a significantly
greater membrane resistance than non-MC3R neurons
(MC3R neuron, 2.12 ± 0.16 G; non-MC3R neuron,
Figure 1. Expression of EYFP in MC3R
neurons of the VTA from a MC3RCre
-EYFP mouse and localization of Cre and
MC3R transcripts in the VTA from a
MC3RCre mouse
A and B, expression of EYFP in coronal brain
slices containing the VTA from a MC3RCre
-EYFP mouse that expresses EYFP in MC3R
neurons: anterior VTA to bregma –3.28 (A),
middle/posterior VTA to bregma –3.4 C–E,
colocalization of MC3R mRNA (blue) and Cre
mRNA (red) in coronal brain slices containing
the VTA from a MC3RCre mouse using
RNAscope ISH at 4× (C), 20× (D) and 40×
(E). Scale bars = 500 μm (A–C),
100 μm (D) and 50 μm (E).
C© 2019 The Authors. The Journal of Physiology C© 2019 The Physiological Society
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Figure 2. Characteristics of VTA MC3R neurons
A and B, average capacitance (A) and membrane resistance (RM) (B) of VTA MC3R and non-MC3R neurons. C,
sample traces from MC3R neurons without (dark grey trace) or with (black trace) H-current and a sample trace
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of H-current in a non-MC3R neuron (light grey trace). D, average amplitude of H-current at –60, –70, –80, –90
and –100 mV for MC3R neurons without H-current, MC3R neurons with H-current and non-MC3R neurons. E,
average amplitude of H-current at –100 mV for MC3R neurons with H-current and non-MC3R neurons. F–G,
average action potential (AP) half-width (F) and rise time (G) of spontaneously firing VTA MC3R and non-MC3R
neurons. H, sample traces of an action potential from a VTA MC3R and a non-MC3R neuron. I, example of a TH+
(Ia–Ic) and a TH- (Id–If) recorded VTA neuron. Neurons were filled with biocytin and labelled for biocytin (red, Ia
and Id) and TH (magenta, Ib and Ie). Colocalization of TH and biocytin (Ic and If). MC3R neurons: n = 59 cells
from 45 mice. Non-MC3R neurons: n = 12 cells from eight mice. MC3R neurons, H-current: n = 34 cells from
30 mice. MC3R neurons, no H-current: n = 25 cells from 24 mice. F–G, MC3R neurons: n = 12 cells from nine
mice. Non-MC3R neurons: n = 8 cells from six mice. Scale bars = 30 pA 500 ms–1 (C) and 20 mV 5 ms–1 (H).
∗∗P < 0.001 ∗P < 0.05.
0.79 ± 0.16 G; mean difference = 1.33; P < 0.001;
Mann–WhitneyU test) (Fig. 2B).H-currentwas present in
34 out of 59 of the MC3R neurons tested and was pre-
sent in all 12 non-MC3R neurons tested (Fig. 2C and
D). However, the H-current was significantly smaller
when the cell was stepped from –60 mV to –100 mV
in MC3R neurons compared to non-MC3R neurons
(MC3R neuron, –13.08 ± 2.22 pA; non-MC3R neuron,
–62.28 ± 19.96 pA; mean difference = 49.2; P < 0.001;
Mann–Whitney U test) (Fig. 2E). We also examined the
basic action potential characteristics of spontaneously
firing MC3R and non-MC3R neurons measured with
whole-cell current clamp. The average action potential
height of MC3R neurons and non-MC3R neurons were
Figure 3. α-MSH increased the spontaneous firing rate of VTA
MC3R neurons in loose cell-attached recordings
A, sample traces of a MC3R neuron before (black trace) and after
(grey trace) α-MSH (1 μM). B, mean effect of α-MSH on the firing
rate of MC3R neurons. C, mean firing rate of MC3R neurons before
and after α-MSH. n = 8 cells from seven mice. Scale bars = 1 s.
∗P < 0.001.
63.66 ± 2.6 mV and 64.9 ± 2.54 mV, respectively,
with no significant difference between the two groups
(mean difference = 1.24; P = 0.748; Student’s t test).
However, the action potential half-width and rise time of
MC3R neurons were significantly greater than the action
potential half-width and rise time of non-MC3R neurons
(half-width: MC3R neuron, 2.76 ± 0.33 ms; non-MC3R
neuron, 1.54 ± 0.23 ms; mean difference = 1.22;
P = 0.014; Student’s t test; rise time: MC3R neuron,
1.01± 0.15ms; non-MC3R neuron, 0.62± 0.07ms;mean
difference = 0.39; P = 0.019; Mann–Whitney U test)
(Fig. 2F–H).We filled a portion of the recordedMC3R and
non-MC3R neurons with biocytin and then performed
post-recording immunohistochemistry for TH to identify
the recorded neurons as dopamine or non-dopamine
neurons. Twelve of the 38 VTA MC3R neurons filled with
biocytin were reliably identified as TH-positive and seven
of the 38 were identified as TH-negative (Fig. 2A, B, E
and I). Three of the eight non-MC3R neurons filled with
biocytin were reliably identified as TH-positive, whereas
none were identified as TH-negative (Fig. 1A, B, E and
I). For both the MC3R and non-MC3R neurons, the
remaining cells either could not be conclusively identified
or were damaged during processing. Thus, MC3Rs are
expressed in both dopamine and non-dopamine VTA
neurons, and VTA MC3R neurons are smaller than
non-MC3R neurons, with a higher membrane resistance,
little to no H-current and broader action potentials.
To determine whether α-MSH affects the activity of
VTA MC3R neurons, we first tested whether α-MSH
changed the spontaneous firing rate of VTA MC3R
neurons in the loose-cell attached configuration. α-MSH
(1 μM) significantly increased the spontaneous firing
rate of VTA MC3R neurons by 0.41 ± 0.07 Hz (before
α-MSH, 2.92 ± 0.41 Hz; after α-MSH, 3.33 ± 0.39 Hz;
P< 0.001; Student’s paired t test) (Fig. 3). Out of the eight
MC3R neurons tested, all exhibited an action potential
width 1.2 ms, suggesting that the MC3R neurons
tested were dopaminergic. A broad action potential
width is a physiological characteristic that is indicative
of dopamine neurons and has repeatedly and reliably
been used to identify dopamine neurons in cell-attached
and extracellular recordings (Ungless et al. 2004; Ford
et al. 2006; Chieng et al. 2011). However, we could
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not use post-recording immunohistochemistry to identify
dopamine neurons in these experiments and, without
validation, cannot conclusively classify these neurons as
dopaminergic. Thus, α-MSH increases the firing of VTA
putative dopamine neurons expressing MC3Rs.
We next confirmed and extended these findings by
testing whether α-MSH increases the firing rate of
VTA MC3R neurons in the whole-cell current clamp
configuration. We included blockers of fast synaptic
currents (10 μM DNQX, 100 μM picrotoxin) in the bath
solution to confirm that the α-MSH induced increase in
MC3R neuron firing rate was a result of a direct action
on MC3Rs and not changes in synaptic transmission.
α-MSH (1 μM) significantly increased the firing rate of
MC3R neurons by 0.42 ± 0.11 Hz in the presence of fast
synaptic blockers (before α-MSH, 1.17 ± 0.21 Hz; after
α-MSH, 1.59 ± 0.15 Hz; P = 0.012; Student’s paired t
test) (Fig. 4A–C). Intracellular Ca2+ plays a key role in
VTA dopamine neuron excitability, firing rate and burst
firing (Grace&Bunney, 1984b, a; Paladini&Roeper, 2014)
and so we next tested whether reduced Ca2+ buffering
affected the α-MSH induced increase in MC3R neuron
firing rate using an internal solution containing a lowCa2+
buffer (1 mM EGTA). α-MSH (1 μM) also significantly
increased the firing rate of MC3R neurons using the 1 mM
EGTA internal solution by 0.51± 0.17Hz (beforeα-MSH,
1.28 ± 0.34 Hz; after α-MSH, 1.78 ± 0.47 Hz; P = 0.028;
Student’s paired t test) (Fig. 4D and E), with no significant
difference between the magnitudes of α-MSH induced
increase in firing rate between the two groups (10 mM
BAPTA, 0.42 ± 0.11 Hz vs. 1 mM EGTA, 0.51 ± 0.17 Hz;
mean difference= 0.09; P= 0.673; Student’s t test). Thus,
Figure 4. α-MSH increased the firing rate of VTA
MC3R neurons in whole-cell current clamp
recordings in the presence of inhibitors of fast
synaptic transmission (DNQX: 10 μm; picrotoxin:
100 μm)
A, sample traces of the firing rate of a MC3R neuron
before (black trace), during and after (grey trace)
α-MSH (1 μM) application. B and D, mean effect of
α-MSH on the firing rate of MC3R neurons using an
internal solution containing 10 mM BAPTA (B) or
1 mM EGTA (D). C and E, mean firing rate of MC3R
neurons before and after α-MSH using an internal
solution containing 10 mM BAPTA (C) or 1 mM EGTA
(E). n = 6 cells from six mice for each group. Scale
bars = 40 mV min–1 (top trace) and 40 mV 4 s–1
(bottom trace). ∗P < 0.05.
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α-MSH increases the firing rate of VTAMC3Rneurons via
a mechanism independent of fast synaptic transmission
and intracellular Ca2+ levels. To identify whether these
MC3Rneuronswere dopaminergic, we labelled theMC3R
neurons with biocytin and stained for TH. Five out of 12
were TH-positive and we were unable to reliably identify
the remaining seven neurons. These experiments further
confirm that α-MSH increases the firing rate of VTA
dopamine neurons expressing MC3Rs.
MC3Rs are only expressed in a subset of VTA neurons
(Lippert et al. 2014) and there is some low level expression
ofMC4Rs in theVTA (Roselli-Rehfuss et al. 1993; Liu et al.
2003; Lippert et al. 2014) and so we next tested whether
the α-MSH induced increase in VTA MC3R neuron
firing rate was specific to VTA MC3R neurons. In these
experiments, we tested the effect ofα-MSHonnon-MC3R
neuron activity under the exact same conditions used to
test the effect of α-MSH on MC3R neuron activity (e.g.
in whole-cell current clamp configuration with blockers
of fast synaptic currents) (Fig. 4C). α-MSH did not
increase the firing rate of non-MC3R expressing VTA
Figure 5. α-MSH did not increase the firing rate of non-MC3R
expressing VTA neurons in whole-cell current clamp
recordings in the presence of inhibitors of fast synaptic
transmission (DNQX: 10 μm; picrotoxin: 100 μm)
A, sample traces of the firing rate of a non-MC3R neuron before
(black trace), during and after (grey trace) α-MSH (1 μM) application.
B, mean effect of α-MSH on the firing rate of non-MC3R neurons. C,
mean firing rate of non-MC3R neurons before and after α-MSH.
n = 5 cells from five mice. Scale bars = 50 mV min–1 (top trace) and
40 mV 4 s–1 (bottom trace). n.s., not significant.
neurons (before α-MSH, 0.70 ± 0.14 Hz, after α-MSH:
0.49 ± 0.13 Hz; P = 0.104; Student’s paired t test)
(Fig. 5). There was a trend toward a decrease in firing
rate (–0.2 ± 0.11 Hz), although this decrease was not
statistically significant (Fig. 5C). The non-MC3R neurons
tested were stained for TH, and three out of five neurons
tested were TH-positive, whereas 2 could not reliably be
identified. Therefore, α-MSH does not increase the firing
rate of non-MC3R expressing dopamine neurons and the
α-MSH induced increase in VTA neuron firing appears to
be specific to VTA MC3R neurons.
α-MSH could increase the activity of VTA MC3R
neurons by direct depolarization or by modifying the
firing properties of the cell (e.g. threshold) independent
of a direct change in membrane potential. To determine
whether α-MSH directly depolarizes MC3R neurons,
we tested the effect of α-MSH on membrane potential
in the presence of TTX (1 μM), DNQX (10 μM) and
picrotoxin (100 μM). α-MSH (1 μM) slightly increased
the membrane potential of MC3R neurons, although this
increase was not statistically significant (before α-MSH,
–53.7 ± 3.7 mV; after α-MSH –52.4 ± 3.6 mV; mean
depolarization = 1.34 ± 0.84 mV; P = 0.177; Student’s
paired t test) (Fig. 6A and B). To confirm and extend
our results, we used voltage clamp to test the effect
of α-MSH on membrane current and slow voltage
ramps (–100 mV to 0 mV 100 mV s−1) in the pre-
sence of TTX (1 μM), DNQX (10 μM) and picrotoxin
(100μM).α-MSH(1μM)didnot affectmembrane current
or membrane resistance in VTA MC3R neurons (RM
before α-MSH, 1413.61 ± 292.72 M; RM after α-MSH
1276.18±210.7M;meandifference=137.43;P=0.156;
Wilcoxin signed-rank test) (Fig. 6C and D). The MC3R
neurons tested in these experiments were also stained
for TH, and four out of 12 were TH-positive, three were
TH-negative and five could not be reliably identified.
We then tested whether α-MSH altered VTA MC3R
neuron firing independent of a direct depolarization by
testing the effect of α-MSH on current-step evoked action
potentials. The neurons were held at –70 mV and a
set of current steps of increasing amplitude (5–50 pA
in 5 pA increments; 2 s each; 1 s inter-step interval)
were applied every minute. α-MSH (1 μM) did not
significantly affect rheobase (i.e. the minimal current
required to reach threshold potential and generate an
action potential) (before α-MSH, 26.9 ± 3.5 pA; after
α-MSH, 25 ± 3 pA; mean difference = 1.9; P = 0.351;
Student’s paired t test) (Fig. 7B and E) or membrane
potential (before α-MSH, –70.6 ± 0.87 mV; after α-MSH,
–68.1 ± 1.7 mV; mean difference = 2.5; P = 0.181;
Student’s paired t test) (Fig. 7C and D). However,
α-MSH (1 μM) did significantly increase the number of
current-evoked action potentials at the 35, 40, 45 and
50 pA current steps in MC3R neurons (significant main
effect of current step, F9,63 = 22.135, P < 0.001) (Fig. 7A
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and B) and significant current-step × α-MSH interaction
(F9,63 = 3.227, P = 0.003; two-way repeated measures
ANOVA). The current-step evoked action potentials were
further analysed at the 40 pA current step because this
step consistently evoked three or four action potentials
at baseline in seven out of eight neurons tested. One
cell was excluded from this analysis because the 40 pA
current step failed to consistently evoke action potentials.
α-MSH significantly decreased the inter-spike interval at
the 40 pA current step (before α-MSH, 119.7 ± 20.8 ms;
after α-MSH, 90.9 ± 12.1 ms; mean difference = 28.8;
P = 0.016; Wilcoxin signed-rank test) (Fig. 7F) and
there was a trend towards a decrease in the latency
to the first spike at the 40 pA current step (before
α-MSH, 1.07 ± 0.13 s; after α-MSH, 0.85 ± 0.07 s;
mean difference = 0.22; P = 0.131; Student’s paired t
test) (Fig. 7G). Thus, α-MSH facilitates MC3R neuron
firing via an activity-dependent mechanism that does not
appear to involve direct depolarization or a change in
rheobase or threshold potential. Consistent with our other
experiments, we stained theseMC3R neurons for TH, and
one out of eight were identified as TH-positive, four as
TH-negative and three could not be reliably identified.
Thus, these results suggest α-MSH increases the firing
rate of both dopamine and non-dopamine VTA MC3R
neurons.
Discussion
In these studies, we have shown that α-MSH significantly
increases the firing rate of VTA MC3R neurons via an
activity-dependent mechanism because α-MSH increased
the activity of MC3R neurons only when the neurons
were firing. α-MSH did slightly increase the membrane
potential of MC3R neurons; therefore, it is possible
that this slight increase in membrane potential caused
a significant increase in MC3R neuron firing. In addition,
α-MSH did not affect rheobase in MC3R neurons,
suggesting that α-MSH does not increase the firing
rate of MC3R neurons by lowering threshold potential.
Furthermore, α-MSH increased the firing rate via a
mechanism independent of fast synaptic transmission
and intracellular Ca2+ levels. Thus, our results suggest
α-MSH increases the firing rate of VTA MC3R neurons
via an activity-dependent mechanism that is independent
of intracellularCa2+ levels or altered synaptic transmission
onto VTA MC3R neurons.
The VTA comprises a heterogeneous population of
neurons including dopamine, GABA and glutamate
neurons that have different projection targets, electro-
physiological characteristics and molecular markers
(Morales & Margolis, 2017). We examined the electro-
physiological characteristics of VTA MC3R neurons and
found that they had a significantly smaller capacitance
compared to non-MC3R neurons, suggesting that MC3R
neurons are smaller than non-MC3R neurons. In
addition, VTA MC3R neurons had a significantly higher
membrane resistance, little to no H-current, and a greater
action potential half-width and rise time compared to
non-MC3R neurons. Previous studies have shown that
the highest levels of VTA MC3R neurons are found
in the ventromedial region of the VTA (Lippert et al.
Figure 6. α-MSH did not significantly affect the membrane potential, current, or resistance of VTAMC3R
neurons in the presence of TTX (1 μm)
A, mean effect of α-MSH (1 μM) on the membrane potential of MC3R neurons. B, mean membrane potential of
MC3R neurons before and after α-MSH. C, mean effect of α-MSH (1 μM) on membrane current of MC3R neurons.
D, mean membrane resistance (RM) of MC3R neurons before and after α-MSH. E, mean effect of α-MSH on slow
voltage ramps (–100 mV to 0 mV 100 mV s−1) before (black trace) and after α-MSH (1 μM; grey trace) in MC3R
neurons. n = 6 cells from five mice for each group.
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2014), and for our experiments, recorded VTA MC3R
neurons were located in more medial regions of the VTA,
whereas recorded non-MC3R neurons were located in the
central to more lateral regions of the VTA. Our results
and the location of MC3R neurons suggests that VTA
dopamine neurons expressing MC3Rs probably project
to the medial PFC (mPFC), NAc core, NAc medial shell
or basolateral amygdala because VTA dopamine neurons
projecting to these areas are significantly smaller than
dopamine neurons projecting to the NAc lateral shell
and are primarily located in the medial posterior VTA
(Lammel et al. 2008). Furthermore, it was previously
shown thatVTAdopamineneuronsprojecting to thebaso-
lateral amygdala and NAc medial shell have a significantly
smaller capacitance, higher membrane resistance and
little to no H-current compared to NAc lateral shell
projecting dopamine neurons (Baimel et al. 2017). In
addition, mPFC, NAc core, NAc medial shell and baso-
lateral amygdala projecting VTA dopamine neurons have
wider action potentials compared to the action potentials
ofNAc lateral shell projectingdopamineneurons (Lammel
et al. 2008; Baimel et al. 2017). Thus, the electrical
properties of VTA MC3R neurons suggest that dopamine
neurons expressing MC3Rs most probably project to
the mPFC, NAc core, NAc medial shell, or basolateral
amygdala and do not project to the NAc lateral shell,
although further experiments are needed to determine
the projection targets of VTA MC3R neurons.
MC3Rs are expressed in both VTA dopamine
and non-dopamine neurons (dopamine: 57%;
non-dopamine: 43%) (Lippert et al. 2014). The
identity of MC3R non-dopamine neurons is currently
unknown and these neurons may be GABAergic or
glutamatergic neurons because both are found in the
Figure 7. α-MSH increased the number of current-step evoked action potentials but did not affect
rheobase in VTA MC3R neurons
Current steps (2 s) of increasing amplitude (5–50 pA) were applied every minute before, during and after α-MSH
(1 μM) application. A, sample traces of a MC3R neuron before (black trace) and after (grey trace) α-MSH. B, mean
effect of α-MSH on the number of action potentials evoked by incrementing 5 pA current-steps (5–50 pA). C and
D, mean effect of α-MSH on membrane potential (C) and mean membrane potential before and after α-MSH (D)
for the MC3R neurons in (B). E and G, mean rheobase (the minimum current step required to initiate an action
potential) (E), mean inter-spike interval at the 40 pA step (F) and mean latency to the first spike at the 40 pA step
(G) before and after α-MSH. n = 7–8 cells from six or seven mice for each group. Scale bars = 40 mV 5 s–1 (left
traces) and 40 mV 2 s–1 (right traces). ∗P < 0.05.
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VTA (Yamaguchi et al. 2007; Nair-Roberts et al. 2008;
Margolis et al. 2012). Previous studies have shown that
intra-VTA α-MSH increases dopamine release in the
NAc and dopamine-dependent behaviours, suggesting
that α-MSH increases VTA dopamine neuron activity
(Torre & Celis, 1986, 1988; Klusa et al. 1999; Lindblom
et al. 2001; Sanchez et al. 2001; Jansone et al. 2004). In
addition, γ-MSH increased the firing rate of a subset of
VTA dopamine neurons in rats (Pandit et al. 2016). In
agreement, our results suggest that α-MSH increases the
firing rate of VTA dopamine neurons expressing MC3Rs.
All of the MC3R neurons tested in the cell-attached
recordings had broad action potential widths (1.2 ms),
which has been shown to reliably identify mouse VTA
dopamine neurons in cell-attached recordings (Ford et al.
2006; Chieng et al. 2011), suggesting that the neurons
recorded in our cell-attached experiments are putative
dopamine neurons. In addition, 12 of the MC3R neurons
tested in our experiments were TH positive. Nevertheless,
our results also suggest that α-MSH increases the firing
rate of VTA non-dopamine MC3R neurons because
seven MC3R neurons were TH negative. Thus, α-MSH
probably increases the firing rate of dopamine and
non-dopamine VTA MC3R neurons. In conclusion,
we have shown that α-MSH increases the firing rate of
VTA dopamine MC3R-expressing neurons, although
α-MSHmay increase the firing rate of VTA GABA and/or
glutamate MC3R-expressing neurons as well, and further
studies will be required to conclusively identify the
specific subtypes of VTA MC3R neurons responding to
α-MSH.
Altering VTA dopamine neuron activity and down-
stream dopamine release affects food intake and feeding
behaviour, although how VTA dopamine neuron activity
regulates feeding behaviour is complex andnot completely
understood (Palmiter, 2007; Kenny, 2011; Volkow et al.
2011). For example, increasing dopamine neuron activity
and dopamine release can both increase and decrease
food intake. Indeed, increasing dopamine release in
the NAc using a low dose of amphetamine increases
food intake, whereas higher doses decrease food intake
in rats (Evans & Vaccarino, 1986) and anorexigenic
(feeding inhibiting) and orexigenic (feeding stimulating)
peptides have both been shown to increase dopamine
neuron activity, although having opposite effects on food
intake (Liu & Borgland, 2015). Furthermore, different
anorexigenic peptides decrease food intake by either
increasing or decreasing dopamine neuron activity and
dopamine release depending on the peptide (Liu &
Borgland, 2015). For example, the anorexigenic peptides
insulin and leptin decrease dopamine neuron activity
and feeding (Hommel et al. 2006; Labouebe et al.
2013; Thompson & Borgland, 2013), although α-MSH
increases NAc dopamine release (Torre & Celis, 1986,
1988; Lindblom et al. 2001; Sanchez et al. 2001; Jansone
et al. 2004) and decreases feeding (Roseberry, 2013; Yen
& Roseberry, 2015; Shanmugarajah et al. 2017). However,
it was previously unknown how α-MSH increased NAc
dopamine release at the cellular level to regulate feeding
behaviour. In the present study, we have identified a novel
mechanism for the control of VTAMC3R neuron activity
byα-MSH.Asa result, these studiesprovide abetterunder-
standing of howα-MSHacts in theVTAat the cellular level
and suggest that intra-VTA α-MSH decreases food intake
and food reward by increasing the activity of a specific
population ofVTAdopamine andnon-dopamine neurons
via an activity-dependent mechanism.
The effect of α-MSH on VTA MC3R neurons probably
occurs via activation ofMC3Rs becauseMC3Rs are highly
expressed in the VTA (Roselli-Rehfuss et al. 1993; Lippert
et al. 2014). It is possible that α-MSH could mediate its
effect on MC3R neurons by acting on MC4Rs as well,
although this appears to be improbable. AlthoughMC4Rs
are also expressed in the VTA, they are expressed at
much lower levels compared to MC3Rs (Roselli-Rehfuss
et al. 1993; Liu et al. 2003; Lippert et al. 2014) and
MC4Rs are most abundantly expressed in caudal regions
of the VTA, whereas MC3Rs are expressed throughout
the rostral-caudal extent of the VTA (Lippert et al. 2014).
Thus, although we cannot rule out the possibility that the
effects of α-MSH on VTA MC3R neuron activity are also
mediated byMC4Rs in some of theMC3R neurons tested,
this appears to be improbable.
We also showed that α-MSH does not significantly
increase the firing rate of non-MC3R expressing VTA
neurons, although there was a trend toward a decrease
in firing rate in these studies because α-MSH reduced
the firing rate of four out of five of the non-MC3R
neurons tested. This decrease in firing rate may be a
result of run down because the firing rate slowly ran
down in most of the recorded neurons. Alternatively,
α-MSH may decrease the firing rate of non-MC3R
expressing VTA dopamine neurons via activation of
dopamine D2 receptors. VTA dopamine neurons release
dopamine from their soma and dendrites (Bjorklund
& Lindvall, 1975; Geffen et al. 1976; Kalivas & Duffy,
1991; Rice et al. 1997; Beckstead et al. 2004) and this
somatodendritic release inhibits neighbouring dopamine
neurons via dopamine D2 receptor-mediated activation
of G-coupled inward rectifying potassium channels
(Aghajanian & Bunney, 1977; Lacey et al. 1987; Mercuri
et al. 1997; Beckstead et al. 2004). Our results suggest
α-MSH increases the firing rate of VTA dopamine-MC3R
neurons and so the increased activity of dopamine-MC3R
neurons could have caused an increase in somatodendritic
dopamine release and inhibition of neighbouring VTA
dopamine neurons, although this possibility remains to be
tested.
The exact mechanisms by which α-MSH increases
VTA MC3R neuron activity are unknown. MC3Rs
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are G protein-coupled receptors that signal via Gs
and thus activate adenylyl cyclase and subsequently
cAMP and protein kinase A (PKA) (Roselli-Rehfuss
et al. 1993). However, additional experiments have
demonstrated that the MC3R is coupled to other
G-proteins and can activate other signalling pathways.
For example, activating MC3Rs in HEK293 cells also
activates mitogen-activated protein kinase (MAPK) via a
Gi protein-phosphoinositide 3-kinase signalling pathway
(Chai et al. 2007). Thus, it is possible thatα-MSH increases
VTA MC3R neuron activity by activating PKA, MAPK or
phosphoinositide 3-kinase and subsequently increasing or
decreasing the conductance of an ion channel current
via its phosphorylation. Indeed, reducing M-current
(a voltage-gated potassium current) in VTA dopamine
neurons significantly decreases the inter-spike interval of
evoked action potentials (Koyama & Appel, 2006) and
blocking A-type current (a low-threshold voltage-gated
potassium current) increases the firing rate and the inward
inter-spike current in VTA dopamine neurons (Khaliq
& Bean, 2008). Thus, α-MSH could increase the firing
rate of VTA MC3R neurons by reducing M-current or
A-type current because α-MSH did significantly decrease
the inter-spike interval of evoked action potentials in VTA
MC3R neurons. In addition, α-MSH could increase the
firing rateofMC3Rneuronsby increasing the conductance
of a Na+ current because spontaneous firing in VTA
dopamine neurons is primarily dependent on two Na+
currents: a TTX insensitive Na+ leak current and a
TTX-sensitive voltage-dependent Na+ current (Khaliq &
Bean, 2010; Gantz et al. 2018). Finally, it is also possible
that α-MSH directly increases VTAMC3R neuron activity
simply via direct depolarization because α-MSH did
slightly depolarize MC3R neurons, although this change
in membrane potential was not statistically significant,
making it difficult to determine the contribution of
this change to the observed increase in firing. Thus,
further experiments are needed to determine how α-MSH
increases VTA MC3R neuron firing rate, as well as to
identify the intracellular signalling pathway mediating
these effects.
In summary, we have shown that α-MSH increases
the firing rate of MC3R expressing VTA neurons via
an activity-dependent mechanism. These results advance
our understanding of the cellular mechanisms by which
intra-VTA α-MSH regulates food intake, food reward and
other dopamine-dependent behaviours, as well as how
intra-VTA α-MSH increases dopamine turnover in the
NAc.
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